articlePubMedDec 1, 2017Closed access

Progress in Nanomedicine: Approved and Investigational Nanodrugs.

PubMed
Indexed inpubmed

Abstract

Nanomedicine is a relatively new and rapidly evolving field combining nanotechnology with the biomedical and pharmaceutical sciences.1-3 Nanoparticles (NPs) can impart many pharmacokinetic, efficacy, safety, and targeting benefits when they are included in drug formulations.1-5 Many nanodrugs have entered clinical practice, and even more are being investigated in clinical trials for a wide variety of indications.2 However, nanopharmaceuticals also face challenges, such as the need for better characterization, possible toxicity issues, a lack of specific regulatory guidelines, cost-benefit considerations, and waning enthusiasm among some health care professionals. 4,5 For these reasons, expectations regarding…

Citation impact

806
total citations
FWCI
37.30
Percentile
100%
References
61
Citations per year

Authors

1

Topics & keywords

Keywords
  • Nanomedicine
  • Medicine
  • Investigational Drugs
  • Clinical trial
  • Nanotechnology
  • Engineering ethics
  • Engineering
  • Internal medicine
No related works found for this paper.